Amicus Therapeutics Inc. (FOLD)

NASDAQ: FOLD · Real-Time Price · USD

6.67

-1.01 (-13.15%)

At close: May 01, 2025, 3:39 PM

Amicus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	528.29M	399.36M	329.23M	305.51M	260.89M	182.24M	91.25M	36.93M	4.96M
Cost of Revenue	52.94M	37.33M	38.6M	34.47M	31.04M	21.96M	14.4M	6.24M	833K
Gross Profit	475.35M	362.03M	290.63M	271.05M	229.84M	160.27M	76.84M	30.69M	4.13M
Operating Income	24.88M	-73.49M	-204.43M	-199.92M	-243.85M	-300.74M	-328.78M	-441.99M	-181.89M
Interest Income	5.41M	7.08M	3.02M	509K	3.23M	10.25M	10.46M	4.1M	1.6M
Pretax Income	-28.76M	-150.1M	-242.04M	-241.55M	-274.25M	-355.91M	-349.09M	-449.12M	-203.78M
Net Income	-56.11M	-151.58M	-236.57M	-250.46M	-276.85M	-356.39M	-349M	-284M	-200.04M
Selling & General & Admin	323.38M	275.27M	213.04M	192.71M	156.41M	169.86M	127.2M	88.67M	71.15M
Research & Development	109.36M	152.38M	276.68M	272.05M	308.44M	286.38M	270.9M	149.31M	104.79M
Other Expenses	17.73M	n/a	5.34M	6.21M	8.85M	4.78M	-5.63M	6.01M	-4.79M
Operating Expenses	450.48M	427.65M	495.06M	470.97M	473.7M	461.01M	402.32M	241.57M	179.19M
Interest Expense	49.6M	50.15M	37.12M	32.47M	22.43M	18.87M	22.4M	17.24M	5.4M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	485.68M	472.85M	533.66M	505.43M	504.74M	482.98M	416.72M	247.81M	180.02M
Income Tax Expense	27.35M	1.48M	-5.47M	8.91M	2.6M	478K	-94K	-165.12M	-3.74M
Shares Outstanding (Basic)	304.38M	295.16M	289.06M	271.42M	258.87M	240.42M	185.79M	153.36M	134.4M
Shares Outstanding (Diluted)	304.38M	295.16M	289.06M	271.42M	258.87M	240.42M	185.79M	153.36M	134.4M
EPS (Basic)	-0.18	-0.51	-0.82	-0.92	-1.07	-1.48	-1.88	-1.85	-1.49
EPS (Diluted)	-0.18	-0.51	-0.82	-0.92	-1.07	-1.48	-1.88	-1.85	-1.49
EBITDA	29.39M	-92.08M	-199.58M	-202.87M	-242.98M	-332.26M	-322.47M	-428.29M	-195.14M
EBIT	20.84M	-99.95M	-204.92M	-209.08M	-251.83M	-337.04M	-326.69M	-431.88M	-198.38M
Depreciation & Amortization	8.55M	7.87M	5.34M	6.21M	8.85M	4.78M	4.22M	3.59M	3.24M